Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPROXEN 375MG TABLET Resolved 2021-02-19 2021-03-17 134439
APO-NAPROXEN 250MG TABLET Resolved 2021-02-26 2021-03-24 134820
APO-NAPROXEN 500MG TABLET Resolved 2021-04-05 2021-05-03 136805
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-12-04 2021-06-14 129608
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-08-11 2022-10-20 166445
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2022-10-20 166601
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-01-06 2023-03-02 180113
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-23 190859
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-06-04 2021-06-14 140423
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-09-24 2021-10-05 146157
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-01-14 2022-02-07 152770
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-01-15 2020-02-01 103370
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-05-01 40351
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2020-12-18 2021-01-19 130410
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-09-04 2018-07-31 20882
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2024-02-09 2024-03-29 219165
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-21 2023-06-23 189991
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-12-28 54297

Showing 2041 to 2060 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-SILDENAFIL 100MG TABLET Discontinued 2018-09-08 2018-09-15 60784
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272

Showing 281 to 300 of 359